| 1 |
Peng Q, Jiang X, Tan S, Xu X, Xia L, Wu N, Lin J, Oyang L, Tang Y, Peng M, Su M, Luo X, Han Y, Liao Q, Zhou Y. Clinical significance and integrative analysis of the cuproptosis-associated genes in head and neck squamous cell carcinoma. Aging (Albany NY) 2023;15. [PMID: 36947706 DOI: 10.18632/aging.204579] [Reference Citation Analysis]
|
| 2 |
Su Q, Hua F, Xiao W, Liu B, Wang D, Qin X. Investigation of Hippo pathway-related prognostic lncRNAs and molecular subtypes in liver hepatocellular carcinoma. Sci Rep 2023;13:4521. [PMID: 36941336 DOI: 10.1038/s41598-023-31754-x] [Reference Citation Analysis]
|
| 3 |
Liu Q, Li R, Wu H, Liang Z. A novel cuproptosis-related gene model predicts outcomes and treatment responses in pancreatic adenocarcinoma. BMC Cancer 2023;23:226. [PMID: 36894917 DOI: 10.1186/s12885-023-10678-9] [Reference Citation Analysis]
|
| 4 |
Xie J, Yang Y, Gao Y, He J. Cuproptosis: mechanisms and links with cancers. Mol Cancer 2023;22:46. [PMID: 36882769 DOI: 10.1186/s12943-023-01732-y] [Reference Citation Analysis]
|
| 5 |
Chen X, Sun M, Feng W, Chen J, Ji X, Xie M, Huang W, Chen X, Zhang B, Nie Y, Fan D, Wu K, Xia L. An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma. Front Genet 2023;14:1056000. [PMID: 36845390 DOI: 10.3389/fgene.2023.1056000] [Reference Citation Analysis]
|
| 6 |
He F, Zeng P, Ma S, Yang X, Liu H, Liu Q, Zhou Y, Zhu H. Identification and validation of a novel cuproptosis-related genes signature associated with prognosis, clinical implications and immunotherapy of hepatocellular carcinoma. Front Pharmacol 2023;14:1088993. [PMID: 36843949 DOI: 10.3389/fphar.2023.1088993] [Reference Citation Analysis]
|
| 7 |
Liu Z, Ma H, Lai Z. The Role of Ferroptosis and Cuproptosis in Curcumin against Hepatocellular Carcinoma. Molecules 2023;28. [PMID: 36838613 DOI: 10.3390/molecules28041623] [Reference Citation Analysis]
|
| 8 |
Hu B, Hounye AH, Wang Z, Qi M, Zhang J. A novel Cuprotosis-related signature predicts the prognosis and selects personal treatments for melanoma based on bioinformatics analysis. Front Oncol 2023;13:1108128. [PMID: 36824136 DOI: 10.3389/fonc.2023.1108128] [Reference Citation Analysis]
|
| 9 |
Cui W, Wang Y, Guo J, Zhang Z. Construction of a cuproptosis-associated long non-coding RNA risk prediction model for pancreatic adenocarcinoma based on the TCGA database. Medicine (Baltimore) 2023;102:e32808. [PMID: 36749249 DOI: 10.1097/MD.0000000000032808] [Reference Citation Analysis]
|
| 10 |
Qin H, Sheng W, Weng J, Li G, Chen Y, Zhu Y, Wang Q, Chen Y, Yang Q, Yu F, Zeng H, Xiong A. Identification and verification of m7G-Related genes as biomarkers for prognosis of sarcoma. Front Genet 2023;14:1101683. [PMID: 36816047 DOI: 10.3389/fgene.2023.1101683] [Reference Citation Analysis]
|
| 11 |
Zhu Y, He J, Li Z, Yang W. Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia. BMC Bioinformatics 2023;24:37. [PMID: 36737692 DOI: 10.1186/s12859-023-05148-9] [Reference Citation Analysis]
|
| 12 |
Sun Q, Qin X, Zhao J, Gao T, Xu Y, Chen G, Bai G, Guo Z, Liu J. Cuproptosis-related LncRNA signatures as a prognostic model for head and neck squamous cell carcinoma. Apoptosis 2023;28:247-62. [PMID: 36344660 DOI: 10.1007/s10495-022-01790-5] [Reference Citation Analysis]
|
| 13 |
Liao F, Yin W, Yao D. A New Cuproptosis-Related LncRNAs Prognostic Signature of Cervical Cancer.. [DOI: 10.21203/rs.3.rs-2510108/v1] [Reference Citation Analysis]
|
| 14 |
Chen Y, Zou X, Ma M, Liu Y, Wang R, Dai Z, Tashiheng Y, Yan Y, Yu X, Wang X, Liu C, Lin X, Cheng H. Expression Profiles of Cuproptosis-Related Genes Determine Distinct Subtypes of Pancreatic Ductal Adenocarcinoma. Curr Oncol 2023;30:1648-62. [PMID: 36826087 DOI: 10.3390/curroncol30020126] [Reference Citation Analysis]
|
| 15 |
Liu L, Zheng J, Xia H, Wu Q, Cai X, Ji L, Sun Y. Construction and comprehensive analysis of a curoptosis-related lncRNA signature for predicting prognosis and immune response in cervical cancer. Front Genet 2023;14:1023613. [PMID: 36777734 DOI: 10.3389/fgene.2023.1023613] [Reference Citation Analysis]
|
| 16 |
Jia M, Li J, Zhang J, Wei N, yin Y, Chen H, Yan S, Wang Y. Identification and Validation of Cuproptosis Related Genes and Signature Markers in Bronchopulmonary Dysplasia Disease using Bioinformatics Analysis and Machine Learning.. [DOI: 10.21203/rs.3.rs-2486668/v1] [Reference Citation Analysis]
|
| 17 |
Shen Y, Li D, Liang Q, Yang M, Pan Y, Li H. Cross-talk between cuproptosis and ferroptosis regulators defines the tumor microenvironment for the prediction of prognosis and therapies in lung adenocarcinoma. Front Immunol 2022;13:1029092. [PMID: 36733399 DOI: 10.3389/fimmu.2022.1029092] [Reference Citation Analysis]
|
| 18 |
Zhang B, Zhang T, Zheng Z, Lin Z, Wang Q, Zheng D, Chen Z, Ma Y. Development and validation of a cuproptosis-associated prognostic model for diffuse large B-cell lymphoma. Front Oncol 2022;12:1020566. [PMID: 36713586 DOI: 10.3389/fonc.2022.1020566] [Reference Citation Analysis]
|
| 19 |
Pang Y, Wang Y, Zhou X, Ni Z, Chen W, Liu Y, Du W. Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma. Int J Mol Sci 2023;24. [PMID: 36674979 DOI: 10.3390/ijms24021464] [Reference Citation Analysis]
|
| 20 |
Ke C, Dai S, Xu F, Yuan J, Fan S, Chen Y, Yang L, Li Y. Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma. BMC Cancer 2023;23:25. [PMID: 36611155 DOI: 10.1186/s12885-022-10461-2] [Reference Citation Analysis]
|
| 21 |
Sun D, Lin S, Qin H, Yang Y, Tong J, Zhi Z, Fan J. Identification of an Eight-Cuproptosis-related lncRNA Signature as a Novel Prognostic Model and Prediction of Immunotherapy Response in Ovarian Cancer.. [DOI: 10.21203/rs.3.rs-2368121/v1] [Reference Citation Analysis]
|
| 22 |
Zhang B, Xie L, Liu J, Liu A, He M. Construction and validation of a cuproptosis-related prognostic model for glioblastoma. Front Immunol 2023;14:1082974. [PMID: 36814929 DOI: 10.3389/fimmu.2023.1082974] [Reference Citation Analysis]
|
| 23 |
Ma C, Li F, He Z, Zhao S, Yang Y, Gu Z. Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology. Front Pharmacol 2023;14:1113808. [PMID: 36874011 DOI: 10.3389/fphar.2023.1113808] [Reference Citation Analysis]
|
| 24 |
Chuanbing Z, Zhengle Z, Ruili D, Kongfan Z, Jing T. Genes Modulating Butyrate Metabolism for Assessing Clinical Prognosis and Responses to Systematic Therapies in Hepatocellular Carcinoma. Biomolecules 2022;13. [PMID: 36671437 DOI: 10.3390/biom13010052] [Reference Citation Analysis]
|
| 25 |
Tang Y, Zhang Q, Tang X, Zhong J, Tang Z, Xu R, Zhu Y. A prognostic risk model of rectal cancer miRNA based on cuproptosis related genes.. [DOI: 10.21203/rs.3.rs-2384346/v1] [Reference Citation Analysis]
|
| 26 |
Zhou Z, Zhou Y, Liu D, Yang Q, Tang M, Liu W. Prognostic and immune correlation evaluation of a novel cuproptosis-related genes signature in hepatocellular carcinoma. Front Pharmacol 2022;13:1074123. [PMID: 36588699 DOI: 10.3389/fphar.2022.1074123] [Reference Citation Analysis]
|
| 27 |
Zou Q, Wang S, Chen Y, Du Q, Zhang C, Liu J, Yao S. A cuproptosis-related gene cluster in prediction of ovarian cancer prognosis and chemotherapeutic response.. [DOI: 10.21203/rs.3.rs-2320013/v1] [Reference Citation Analysis]
|
| 28 |
Huang J, Chen M, Pei W, Xu Z, Ning J, Chen C. Distinct tumor microenvironment landscapes in gastric cancer classified by cuproptosis-related lncRNAs. J Cancer 2022;13:3687-700. [PMID: 36606199 DOI: 10.7150/jca.79640] [Reference Citation Analysis]
|
| 29 |
Chen J, Guan Y, Li C, Du H, Liang C. Identification and validation of a novel cuproptosis-related lncRNA gene signature to predict prognosis and immune response in bladder cancer. Discov Oncol 2022;13:133. [PMID: 36454396 DOI: 10.1007/s12672-022-00596-w] [Reference Citation Analysis]
|
| 30 |
Luo L, Li A, Fu S, Du W, He L, Zhang X, Wang Y, Zhou Y, Yunpeng Y, Li Z, Hong S. [Cuproptosis-related immune gene signature predicts clinical benefits from anti-PD-1/PD-L1 therapy in non-small-cell lung cancer. Immunol Res 2022. [DOI: 10.1007/s12026-022-09335-3] [Reference Citation Analysis]
|
| 31 |
Liu Z, Zhu F, Zhang P, Qian B, Liu W, Xiao Y, Chen N, He Q, Xiao J. Construction of cuproptosis-related gene signature to predict the prognosis and immunotherapy efficacy of patients with bladder cancer through bioinformatics analysis and experimental validation. Front Genet 2022;13:1074981. [PMID: 36506302 DOI: 10.3389/fgene.2022.1074981] [Reference Citation Analysis]
|
| 32 |
Chen K, Wang J, Xiao J, Li Z, Zhao X, Chen X, Meng X, Feng J. A novel cuproptosis-related prognostic long non-coding RNAs signature model in neuroblastoma.. [DOI: 10.21203/rs.3.rs-2259371/v1] [Reference Citation Analysis]
|
| 33 |
He M, Gu W, Gao Y, Liu Y, Liu J, Li Z. Molecular subtypes and a prognostic model for hepatocellular carcinoma based on immune- and immunogenic cell death-related lncRNAs. Front Immunol 2022;13:1043827. [PMID: 36479122 DOI: 10.3389/fimmu.2022.1043827] [Reference Citation Analysis]
|
| 34 |
Zhu Y, He J, Li Z, Yang W. Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia.. [DOI: 10.21203/rs.3.rs-2243342/v1] [Reference Citation Analysis]
|
| 35 |
Bai Y, Zhang Q, Liu F, Quan J. A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer. Front Immunol 2022;13:1027449. [PMID: 36451815 DOI: 10.3389/fimmu.2022.1027449] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 36 |
Zhu B, Wang S, Wang R, Wang X. Identification of molecular subtypes and a six-gene risk model related to cuproptosis for triple negative breast cancer. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1022236] [Reference Citation Analysis]
|
| 37 |
Song X, Hou L, Zhao Y, Guan Q, Li Z. Metal-dependent programmed cell death-related lncRNA prognostic signatures and natural drug sensitivity prediction for gastric cancer. Front Pharmacol 2022;13:1039499. [DOI: 10.3389/fphar.2022.1039499] [Reference Citation Analysis]
|
| 38 |
Zhang Q, Ma L, Zhou H, Zhou Y, Liu S, Li Q. A prognostic signature of cuproptosis and TCA-related genes for hepatocellular carcinoma. Front Oncol 2022;12:1040736. [DOI: 10.3389/fonc.2022.1040736] [Reference Citation Analysis]
|
| 39 |
Huang EM, Ma N, Ma T, Zhou JY, Yang WS, Liu CX, Hou ZH, Chen S, Zong Z, Zeng B, Li YR, Zhou TC. Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma. World J Gastrointest Oncol 2022; 14(10): 1981-2003 [DOI: 10.4251/wjgo.v14.i10.1981] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 40 |
Wang Z, Yao J, Dong T, Niu X. Definition of a Novel Cuproptosis-Relevant lncRNA Signature for Uncovering Distinct Survival, Genomic Alterations, and Treatment Implications in Lung Adenocarcinoma. J Immunol Res 2022;2022:2756611. [PMID: 36281357 DOI: 10.1155/2022/2756611] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 41 |
Zhao X, Chen J, Yin S, Shi J, Zheng M, He C, Meng H, Han Y, Han J, Guo J, Yuan Z, Wang Y. The expression of cuproptosis-related genes in hepatocellular carcinoma and their relationships with prognosis. Front Oncol 2022;12:992468. [DOI: 10.3389/fonc.2022.992468] [Reference Citation Analysis]
|
| 42 |
Tang X, Guo T, Wu X, Gan X, Wang Y, Jia F, Zhang Y, Xing X, Gao X, Li Z. Clinical Significance and Immune Infiltration Analyses of the Cuproptosis-Related Human Copper Proteome in Gastric Cancer. Biomolecules 2022;12. [PMID: 36291668 DOI: 10.3390/biom12101459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 43 |
Li M, Song Q, Bai Y, Hua F, Wu T, Liu J. Comprehensive analysis of cuproptosis in immune response and prognosis of osteosarcoma. Front Pharmacol 2022;13:992431. [DOI: 10.3389/fphar.2022.992431] [Reference Citation Analysis]
|
| 44 |
Wen Dong Bai, Jun Yu Liu, Miao Li, Xi Yang, Yu Lan Wang, Guang Jun Wang, Shi Chao Li. A Novel Cuproptosis-Related Signature Identified DLAT as a Prognostic Biomarker for Hepatocellular Carcinoma Patients. World J Oncol 2022;13. [PMID: 36406193 DOI: 10.14740/wjon1529] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 45 |
Zhao C, Zhang Z, Jing T. A novel signature of combing cuproptosis- with ferroptosis-related genes for prediction of prognosis, immunologic therapy responses and drug sensitivity in hepatocellular carcinoma. Front Oncol 2022;12:1000993. [DOI: 10.3389/fonc.2022.1000993] [Reference Citation Analysis]
|
| 46 |
Liu Q, Wu H. A Novel Cuproptosis-Related Gene Model Predicts Outcomes and Treatment Responses in Pancreatic Adenocarcinoma.. [DOI: 10.21203/rs.3.rs-2030022/v1] [Reference Citation Analysis]
|
| 47 |
Farzaneh M, Ghasemian M, Ghaedrahmati F, Poodineh J, Najafi S, Masoodi T, Kurniawan D, Uddin S, Azizidoost S. Functional roles of lncRNA-TUG1 in hepatocellular carcinoma. Life Sci 2022;308:120974. [PMID: 36126725 DOI: 10.1016/j.lfs.2022.120974] [Reference Citation Analysis]
|
| 48 |
Zhang Y, Li X, Li X, Zhao Y, Zhou T, Jiang X, Wen Y, Meng W, Li S. Comprehensive analysis of cuproptosis-related long noncoding RNA immune infiltration and prediction of prognosis in patients with bladder cancer. Front Genet 2022;13:990326. [DOI: 10.3389/fgene.2022.990326] [Reference Citation Analysis]
|
| 49 |
Zhang S, Zhang L, Lu H, Yao Y, Liu X, Hou J. A cuproptosis and copper metabolism–related gene prognostic index for head and neck squamous cell carcinoma. Front Oncol 2022;12:955336. [DOI: 10.3389/fonc.2022.955336] [Reference Citation Analysis]
|
